Brian Wigdahl

TL;DR: These results uniquely differentiate the involvement of DCs in early cell-free versus late cell-associated infection of HTLV-1 and highlight a significant aspect of viral immunopathogenesis related to the progression of adult T cell leukemia and HT LV-1-associated myelopathy/tropical spastic paraparesis after the initial infection.

TL;DR: In this paper, non-thermal plasma (NTP) was used to modulate the immune response to HIV-1 that involves the use of NTP, which is an ionized gas containing various reactive oxygen and nitrogen species (RONS).

TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, which aims to provide real-time information about the immune response to Epstein-Barr virus infection.

TL;DR: A review summarizes the opportunities for nonthermal plasma for immunization and therapeutic purposes and suggests that plasma could play an important role in improving efficacy of existing vaccines and overcoming some of the limitations and challenges with current vaccination strategies.

TL;DR: The potential pharmacological approaches to target viral persistence and enhance effective transcription to purge the virus in cellular reservoirs, especially within the central nervous system, and the novel therapeutics that are currently in various stages of development to achieve a much superior prognosis for the HIV-1-infected population are discussed.